Linked Life Data

16699858

Source:http://linkedlifedata.com/resource/pubmed/id/16699858

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-5-15
pubmed:abstractText
The management of patients with lamivudine-resistant mutants remains challenging, and no clear evidence has been presented concerning the discontinuation of lamivudine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0944-1174
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
240-9
pubmed:meshHeading
pubmed-meshheading:16699858-Adolescent, pubmed-meshheading:16699858-Adult, pubmed-meshheading:16699858-Aged, pubmed-meshheading:16699858-Alanine Transaminase, pubmed-meshheading:16699858-Bilirubin, pubmed-meshheading:16699858-Biological Markers, pubmed-meshheading:16699858-DNA, Viral, pubmed-meshheading:16699858-Disease Progression, pubmed-meshheading:16699858-Drug Resistance, Viral, pubmed-meshheading:16699858-Female, pubmed-meshheading:16699858-Follow-Up Studies, pubmed-meshheading:16699858-Hepatitis B, Chronic, pubmed-meshheading:16699858-Hepatitis B e Antigens, pubmed-meshheading:16699858-Hepatitis B virus, pubmed-meshheading:16699858-Humans, pubmed-meshheading:16699858-Korea, pubmed-meshheading:16699858-Lamivudine, pubmed-meshheading:16699858-Liver Failure, pubmed-meshheading:16699858-Male, pubmed-meshheading:16699858-Middle Aged, pubmed-meshheading:16699858-Multivariate Analysis, pubmed-meshheading:16699858-Mutation, pubmed-meshheading:16699858-Platelet Count, pubmed-meshheading:16699858-Predictive Value of Tests, pubmed-meshheading:16699858-Prospective Studies, pubmed-meshheading:16699858-Prothrombin Time, pubmed-meshheading:16699858-Reverse Transcriptase Inhibitors, pubmed-meshheading:16699858-Risk Factors, pubmed-meshheading:16699858-Serum Albumin
pubmed:year
2006
pubmed:articleTitle
High rates of progressive hepatic functional deterioration whether lamivudine therapy is continued or discontinued after emergence of a lamivudine-resistant mutant: a prospective randomized controlled study.
pubmed:affiliation
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul, 110-744, Korea.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't